| Entry |
|
|---|
| Name |
Methsuximide (USP);
Mesuximide (INN);
Celontin (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C12H13NO2
|
|---|
| Exact mass |
203.0946
|
|---|
| Mol weight |
203.2371
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02033 Succinimide antiepileptic
|
|---|
| Remark |
|
|---|
| Efficacy |
Anticonvulsant |
|---|
| Comment |
Succinimide derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AD Succinimide derivatives
N03AD03 Mesuximide
D00404 Methsuximide (USP) <US>
USP drug classification [BR:br08302]
Anticonvulsants
Calcium Channel Modifying Agents
Methsuximide
D00404 Methsuximide (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02033 Succinimide antiepileptic
D00404 Methsuximide
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D00404 Methsuximide
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-T
D00404 Methsuximide (USP) <US>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1z C 32.0526 -17.2077
2 C8y C 30.9140 -17.9062
3 C5x C 32.0639 -15.8129
4 C1x C 33.4652 -17.5871
5 C8x C 30.9140 -19.3029
6 C8x C 29.7110 -17.2077
7 N1y N 33.3738 -15.3227
8 O5x O 30.9048 -15.0351
9 C5x C 34.2357 -16.4173
10 C8x C 29.7110 -20.0012
11 C8x C 28.4961 -17.9062
12 O5x O 35.6329 -16.4290
13 C8x C 28.4961 -19.3029
14 C1a C 32.0526 -18.6077
15 C1a C 33.7503 -13.9772
BOND 16
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 3 8 2
8 4 9 1
9 5 10 2
10 6 11 1
11 9 12 2
12 10 13 1
13 7 9 1
14 11 13 2
15 1 14 1
16 7 15 1
|
|---|
